Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CathRx is an Australian medical device company specializing in the design, manufacture, and distribution of advanced cardiac electrophysiology (EP) catheters. The company is best known for its proprietary modular catheter technology, which allows for the reprocessing and reuse of high-precision diagnostic and ablation tools, significantly reducing healthcare costs and environmental waste. Their product portfolio, marketed under the Khelix brand, includes steerable diagnostic catheters and specialized mapping tools used to treat cardiac arrhythmias such as atrial fibrillation. CathRx's unique approach combines the performance of premium single-use devices with a sustainable, multi-use economic model.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CathRx.